Valeant CEO Explains Why The Company Is Acquiring Salix For $10.1 Billion Cash Instead Of An Equity Offering
February 23, 2015 at 14:27 PM EST
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) announced earlier Monday that it will be acquiring Salix Pharmaceuticals, Ltd. (NASDAQ: ...